Novartis CEO Vas Narasimhan is doubling down on his $5 billion peak sales projection for Pluvicto, even as the company has given up on a label expansion in Europe.
A research letter published on Monday in JAMA Pediatrics argues that paternal mortality deserve more attention
Healthcare continues to face tight margins, patient expectations keep climbing and clinical and operational leaders are being asked to do more with the teams and tools …
For 40 years, it has been clear that Republican-nominated justices are more likely to peel off and side with the liberal bloc than the other way …
Sen. Jack Reed (D-R.I.), the ranking member on the Senate Armed Services Committee, said Sunday that there are no “timeouts” when it comes to the 60-day …